Attributes | Values |
---|
rdf:type
| |
http://linked.open...gbank/description
| - A cyclohexylamido analog of penicillanic acid. [PubChem] (en)
|
http://linked.open...gy/drugbank/group
| |
http://linked.open...ugbank/indication
| - For the treatment of bacterial infections caused by susceptible organisms. (en)
|
http://linked.open...bank/manufacturer
| |
sameAs
| |
Title
| |
adms:identifier
| |
http://linked.open...mechanismOfAction
| - The bactericidal activity of cyclacillin results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). Cyclacillin is stable in the presence of a variety of b-lactamases, including penicillinases and some cephalosporinases. (en)
|
http://linked.open.../drugbank/synonym
| - Cyclacillin (en)
- Bastcillin (en)
- Calthor (en)
- Citosarin (en)
- Cyclapen (en)
- Cyclapen-W (en)
- Syngacillin (en)
- Ultracillin (en)
- Vastcillin (en)
- Vipicil (en)
- Wyvital (en)
- Aminocyclohexylpenicillin (en)
- Ciclacillin (en)
- Ciclacillum (en)
- (2S,5R,6R)-6-{[(1-aminocyclohexyl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (en)
- (1-Aminocyclohexyl)penicillin (en)
- 6-(1-Aminocyclohexanecarboxamido)penicillanic acid (en)
- 6-(1-Aminocyclohexylcarboxamido)penicillanic acid (en)
- Ciclacilina (en)
- Ciclacilline (en)
- Ciclacillinum (en)
|
http://linked.open...drugbank/toxicity
| - Symptoms of overdose include severe diarrhea, nausea and vomiting. (en)
|
http://linked.open...ynthesisReference
| - Alburn, H.E., Grant, N.H. and Fletcher, H. Ill; US.Patent 3,194,802; assigned to American Home Products Corporation. Robinson, C.A. and Nescio, J.J.; US.Patent 3,478,018; November 11,1969; assigned to American Home Products Corporation. (en)
|
http://linked.open...ugbank/IUPAC-Name
| |
http://linked.open...gy/drugbank/InChI
| |
http://linked.open...Molecular-Formula
| |
http://linked.open.../Molecular-Weight
| |
http://linked.open...noisotopic-Weight
| |
http://linked.open...y/drugbank/SMILES
| |
http://linked.open.../Water-Solubility
| |
http://linked.open...ogy/drugbank/logP
| |
http://linked.open...ogy/drugbank/logS
| |
http://linked.open...nd-Acceptor-Count
| |
http://linked.open...-Bond-Donor-Count
| |
http://linked.open...drugbank/InChIKey
| |
http://linked.open...urface-Area--PSA-
| |
http://linked.open...nk/Polarizability
| |
http://linked.open...bank/Refractivity
| |
http://linked.open...atable-Bond-Count
| |
http://linked.open...ugbank/absorption
| - Moderately absorbed. (en)
|
http://linked.open.../affectedOrganism
| - Enteric bacteria and other eubacteria (en)
- Streptococcus pneumoniae (en)
- Haemophilus influenzae (en)
|
http://linked.open...casRegistryNumber
| |
http://linked.open...drugbank/category
| |
http://linked.open...k/Bioavailability
| |
http://linked.open...bank/Ghose-Filter
| |
http://linked.open...nk/MDDR-Like-Rule
| |
http://linked.open...ank/Melting-Point
| |
http://linked.open...k/Number-of-Rings
| |
http://linked.open...siological-Charge
| |
http://linked.open...bank/Rule-of-Five
| |
http://linked.open...tional-IUPAC-Name
| |
http://linked.open...strongest-acidic-
| |
http://linked.open...-strongest-basic-
| |